JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Alterations in Intestinal Mucosal Barrier Visualized by Confocal Laser Endomicroscopy in Liver Cirrhosis: A Pilot Trial (AMBIC)

  • 0Department of Gastroenterology, Hospital Asklepios Klinikum Schwalmstadt, Krankenhausstraße 27, 34613 Schwalmstadt, Germany.
Diagnostics (basel, Switzerland) +

|

August 10, 2024

|

August 10, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

This study found increased intestinal permeability in liver cirrhosis patients using confocal laser endomicroscopy. This may help identify patients at risk for spontaneous bacterial peritonitis and guide prophylactic antibiotic treatment.

Area Of Science

  • Gastroenterology and Hepatology
  • Medical Imaging
  • Infectious Diseases

Background

  • Chronic liver disease and cirrhosis are global health issues.
  • Spontaneous bacterial peritonitis (SBP) is a severe complication of cirrhosis, reducing survival.
  • Current guidelines suggest paracentesis before antibiotic prophylaxis for SBP.

Purpose Of The Study

  • To investigate and quantify intestinal integrity in liver cirrhosis patients.
  • To correlate increased intestinal permeability with the incidence of SBP.
  • To assess the utility of confocal laser endomicroscopy (CLE) for evaluating intestinal permeability in vivo.

Main Methods

  • 14 liver cirrhosis patients were included for the study.
  • Confocal laser endomicroscopy (CLE) was used for in vivo imaging of intestinal surfaces.
  • Analysis of "optical biopsies" focused on identifying functional and structural barrier defects.

Main Results

  • CLE revealed increased intestinal permeability in liver cirrhosis patients.
  • Findings align with previous studies using different assessment methods.
  • Statistical relevance was limited due to small sample size.

Conclusions

  • Previously published permeability scores are applicable to liver cirrhosis patients.
  • This is the first study to investigate intestinal permeability in vivo using CLE in this population.
  • Further research is needed to identify at-risk patients and develop less invasive diagnostic criteria for prophylactic antibiotic treatment.

Keywords: